Literature DB >> 3488271

Molecular analysis of membrane immunoglobulin-negative variants.

H A Irick, R W Andrews, I H Yang, R A Blanton, C H Sibley.   

Abstract

The mouse B-cell lymphoma WEHI 279.1 is a tumor which synthesizes both membrane and secreted immunoglobulin M (IgM). We have immunoselected variants which fail to express the membrane form (mIgM-); the most frequently isolated phenotype is a complete loss of both membrane expression and synthesis of the mu heavy chain within the cells. We have chosen four of these mIgM- mutants for detailed molecular investigation. One of these has suffered a large deletion which covers the region of chromosome 12 containing the expressed mu gene, but three have no detectable changes in the DNA arrangement of the mu gene. All of the mutants, including the deletion mutant, synthesize 10-30% of the wild-type level of cytoplasmic mu RNA; however, none is the appropriate size for membrane mu (mu m) or secreted mu (mu s) message. Based on our studies of the deletion mutant, which retains its nonproductively arranged allele, at least some of these RNAs may be 'sterile' transcripts from the nonproductively arranged allele. However, if all of these mRNAs derive from the other allele, they represent a substantial elevation of these sterile messages relative to the wild-type level. Furthermore, the three nondeletion mutants transcribe mu RNA at a level indistinguishable from the wild type. It is likely that their defects lie in the stability, processing, or transport of the mu RNA within the nucleus. Somatic cell hybrids between P3X and the IgM- variants produced mostly mIgM- hybrids. However, a few mIgM+ hybrids were produced, suggesting that the mu- defects may be partly complemented by the P3X fusion partner.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488271     DOI: 10.1007/BF00372292

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  38 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Assembly and secretion of pentameric IgM in a fusion between a nonsecreting B cell lymphoma and an IgG-secreting plasmacytoma.

Authors:  W C Raschke; E L Mather; M E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

Review 3.  Flow cytometry analysis of murine B cell lymphoma differentiation.

Authors:  N L Warner; M J Daley; J Richey; C Spellman
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

Review 4.  Transfer and expression of immunoglobulin genes.

Authors:  S L Morrison; V T Oi
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

5.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

6.  High-affinity monoclonal antibodies to the cardiac glycoside, digoxin.

Authors:  M M Hunter; M N Margolies; A Ju; E Haber
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

7.  Expression of immunoglobulin heavy chain at a high level in the absence of a proposed immunoglobulin enhancer element in cis.

Authors:  M R Wabl; P D Burrows
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Rearrangement of immunoglobulin genes.

Authors:  R Wilson; J Miller; U Storb
Journal:  Biochemistry       Date:  1979-10-30       Impact factor: 3.162

9.  Tubulin genes are tandemly linked and clustered in the genome of trypanosoma brucei.

Authors:  L S Thomashow; M Milhausen; W J Rutter; N Agabian
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

10.  Expression of a microinjected immunoglobulin gene in the spleen of transgenic mice.

Authors:  R L Brinster; K A Ritchie; R E Hammer; R L O'Brien; B Arp; U Storb
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.